Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
3.450
-0.190 (-5.22%)
Oct 26, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Market Cap
Armata Pharmaceuticals has a market cap or net worth of $128.28 million as of October 26, 2026. It is the 23,123rd most valuable company in the world and the 3,875th biggest in the United States. Its market cap has decreased by 41.57% in one year.
Market Cap
128.28M
Enterprise Value
418.28M
1-Year Change
-41.57%
Global Rank
Country Rank
#3,875 United States
Category
ChartMarket Cap Chart
Since May 10, 2019, Armata Pharmaceuticals's market cap has increased from $46.31M to $128.28M, an increase of 176.97%. That is a compound annual growth rate of 14.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 128.28M | -43.89% |
| Dec 31, 2025 | 228.64M | 241.56% |
| Dec 31, 2024 | 66.94M | -42.84% |
| Dec 29, 2023 | 117.11M | 161.30% |
| Dec 30, 2022 | 44.82M | -69.80% |
| Dec 31, 2021 | 148.43M | 165.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atrium Therapeutics | 140.27M |
| Codexis | 140.17M |
| TuHURA Biosciences | 138.92M |
| Satellos Bioscience | 138.49M |
| Protara Therapeutics | 137.69M |
| Compass Therapeutics | 137.05M |
| Innate Pharma | 135.78M |
| Cue Biopharma | 135.55M |